Twelfth EDCTP Forum

15–20 Jun 2025 | Kigali, Rwanda

Project cooperationUpdated on 16 June 2025

ETVAX prevention of MSD

Björn Sjöstrand

CEO at Scandinavian Biopharma

Stockholm, Sweden

About

An oral vaccine covering >90% of the circulating ETEC strains

We have generated very promicing efficacy results in a large (5000) placebo controlled study in Gambian infants against both ETEC and also all cause diarrhea.

Organisation

Scandinavian Biopharma

Private company

Solna, Sweden

Similar opportunities